首页> 外文期刊>International journal of urology: official journal of the Japanese Urological Association >Inhibitory effect of clotrimazole on angiogenesis associated with bladder epithelium proliferation in rats.
【24h】

Inhibitory effect of clotrimazole on angiogenesis associated with bladder epithelium proliferation in rats.

机译:克霉唑对大鼠膀胱上皮细胞增殖相关血管生成的抑制作用。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Up-regulation of epithelial vascular endothelial growth factor (VEGF) expression was recently reported at an early stage of bladder carcinogenesis in rats. Subsequently, clotrimazole (CLT) was reported to exert an inhibitory effect on the in vitro proliferation of vascular endothelial cells stimulated by VEGF. The present study was performed to evaluate the effect of CLT on the initial stage of N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN)-induced carcinogenesis of the urinary bladder in rats. METHODS: Seven-week-old-female Wistar rats were divided into both a control group and the other four groups that were allowed free access to drinking water containing 0.05%BBN. Two groups of rats (10-CLT and 20-CLT) received CLT (100 mg/kg per day) once daily by gavage for 10 and 20 weeks, respectively. The other two groups of rats (10-BBN and 20-BBN) were maintained on the same BBN-containing drinking water for 10 and 20 weeks, respectively, without receiving CLT. After removing the urinary bladder of each rat, expression of VEGF and VEGF receptor FLT1, and new capillaries were examined by immunohistochemical staining. VEGF mRNA was detected by the reverse transcription polymerase chain reaction. RESULTS: The ratio of VEGF-positive cells and the expression of VEGF mRNA were lower in the 20-CLT group than in the 10-BBN group. Newly formed capillaries in the 20-CLT group were significantly decreased compared with those in the 10-BBN group. CONCLUSION: These quantitative data suggested that CLT can inhibit VEGF expression in vivo and hence inhibit angiogenesis in the early stages of bladder carcinoma.
机译:背景:最近报道在大鼠膀胱癌发生的早期阶段上皮血管内皮生长因子(VEGF)的表达上调。随后,据报道克霉唑(CLT)对VEGF刺激的血管内皮细胞的体外增殖具有抑制作用。进行本研究以评估CLT对N-丁基-N-(4-羟丁基)亚硝胺(BBN)诱导的大鼠膀胱癌发生初期的影响。方法:将7周龄的雌性Wistar大鼠分为对照组和其他四组,分别允许其自由饮用含0.05%BBN的饮用水。两组大鼠(10-CLT和20-CLT)每天分别通过管饲法分别接受CLT(每天100 mg / kg)治疗10和20周。其他两组大鼠(10-BBN和20-BBN)分别在相同的含BBN的饮用水中维持10周和20周,而未接受CLT。取出每只大鼠的膀胱后,通过免疫组织化学染色检查VEGF和VEGF受体FLT1的表达以及新的毛细血管。通过逆转录聚合酶链反应检测VEGF mRNA。结果:20-CLT组的VEGF阳性细胞比例和VEGF mRNA的表达均低于10-BBN组。与10-BBN组相比,20-CLT组中新形成的毛细血管明显减少。结论:这些定量数据表明CLT可以抑制体内VEGF的表达,从而抑制膀胱癌早期的血管生成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号